Arbutus Biopharma (ABUS) Q2 2024 Earnings Report

1,286 Followers

ABUS Q2 2024 EPS Results

Actual EPS-$0.11

Consensus EPS-$0.10

Beat/MissMissed by -$0.01

One Year Ago EPS-$0.10

Actual Revenue$1.73M

Expected Revenue$1.77M

Beat/MissMissed by -$40.00K

YoY Revenue Growth-62.89%

QuarterQ2 2024

Date08/01/2024

TimeBefore Open

Conference CallThursday, August 1, 2024

ABUS Upcoming Earnings

Arbutus Biopharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

ABUS Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-0.02 / -	-0.04	―
Aug 12, 2026	2026 (Q2)	-0.02 / -0.03	0.01	-400.00% (-0.04)
May 13, 2026	2026 (Q1)	-0.03 / 0.87	-0.13	769.23% (+1.00)
Mar 23, 2026	2025 (Q4)	-0.04 / -0.01	-0.07	85.71% (+0.06)
Nov 13, 2025	2025 (Q3)	-0.03 / -0.04	-0.1	60.00% (+0.06)
Aug 06, 2025	2025 (Q2)	-0.05 / 0.01	-0.11	109.09% (+0.12)
May 14, 2025	2025 (Q1)	-0.10 / -0.13	-0.1	-30.00% (-0.03)
Mar 27, 2025	2024 (Q4)	-0.08 / -0.07	-0.12	41.67% (+0.05)
Nov 06, 2024	2024 (Q3)	-0.09 / -0.10	-0.12	16.67% (+0.02)
Aug 01, 2024	2024 (Q2)	-0.10 / -0.11	-0.1	-10.00% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed